With its standardised data, WHODrug Global is the first point of reference in clinical trials and post-marketing surveillance.
The WHODrug portfolio of trusted and unique products and services increases patient safety by guaranteeing the effective and efficient identification of medicines. By using WHODrug Global, you will get a better understanding of patient profiles and improve your analysis of underlying treatments and safety concerns.
As a non-profit foundation, UMC uses the income generated by sales of the WHODrug portfolio of products and services to support and develop pharmacovigilance around the world.
WHODrug Koda is a powerful and fully automated drug coding assistant that uses AI and advanced algorithms for more efficient and consistent drug coding. It is available now as an add-on to your existing WHODrug Global subscription.